Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Nowacki

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2007
Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trialLucyna Pietrzak, Krzysztof Bujko, Marek P Nowacki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyK Bujko, M P Nowacki, A Nasierowska-Guttmejer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2009
Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor respondersKrzysztof Bujko, Piotr Richter, Milena Kołodziejczyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
The New England Journal of Medicine|July 1, 2005
Capecitabine as adjuvant treatment for stage III colon cancerChris Twelves, Alfred Wong, Marek P Nowacki, et al.
Journal of Medical Genetics|July 13, 2002
Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL geneC Cybulski, K Krzystolik, A Murgia, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2007
Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomised trialLucyna Pietrzak, Krzysztof Bujko, Marek P Nowacki, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2004
Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyK Bujko, M P Nowacki, A Nasierowska-Guttmejer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 20, 2009
Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor respondersKrzysztof Bujko, Piotr Richter, Milena Kołodziejczyk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation statusEric Van Cutsem, Claus-Henning Köhne, István Láng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2006
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patientsHans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, et al.
The New England Journal of Medicine|July 1, 2005
Capecitabine as adjuvant treatment for stage III colon cancerChris Twelves, Alfred Wong, Marek P Nowacki, et al.
Journal of Medical Genetics|July 13, 2002
Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL geneC Cybulski, K Krzystolik, A Murgia, et al.
Pageof 13